May 22, 2025 FDA Approves Mepolizumab for Eosinophilic COPD Nucala gains FDA approval to treat chronic obstructive pulmonary disease, expanding its use to patients with eosinophilic inflammation. Conexiant
May 22, 2025 Forsyth Friday: Scientists draw insight into human hypomineralization treatment by examining pig teeth ADA News
May 06, 2025 Smoking Cessation May Be Critical to Mitigate Burden of Second Primary Cancers The ASCO Post
April 29, 2025 AACR 2025: Oral HER2-Targeted Therapy for Advanced HER2-Mutated Lung Cancer The ASCO Post
November 17, 2023 Extensive-Stage Small Cell Lung Cancer: Triplet Combination vs Chemotherapy Alone The ASCO Post
November 16, 2023 EGFR Tyrosine Kinase Inhibitors vs Durvalumab in EGFR-Mutated NSCLC: Impact on Survival The ASCO Post
November 17, 2023 Taiwanese Program Shows Potential for Detecting Early-Stage Lung Cancer The ASCO Post
July 12, 2023 Changing How Immune Checkpoint Inhibitors Are Delivered Could Reduce Costs by 14%, Study Finds The ASCO Post